Vanda Pharmaceuticals Inc. ($VNDA)
Birznieks Gunther โ SVP, Business Development
Shares
125,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 12, 2026
EPS:Est: -2.18
Revenue:Est: $59.27M
Transaction Details
| Insider | Birznieks Gunther |
|---|---|
| Title | SVP, Business Development |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 18, 2026 |
| Shares Purchased | 125,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 536,628 |
| Derivative | No |
| Accession Number | 0001193125-26-059784 |
| Document | View SEC Filing |